COMMUNIQUÉS West-GlobeNewswire

Curium Announces Approval of Generic DTPA - Kit for the Preparation of Technetium Tc 99m Pentetate Injection in the U.S.

02/04/2025 - 06:01

ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m Pentetate Injection, often [...]

Respilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesn’t Want You to Know

02/04/2025 - 02:29

Thousands Are Ditching Inhalers and Breathing Easier with This Surprising Lung Supplement Backed by Nature and Science JUPITER, FLORIDA, April 02, 2025 (GLOBE NEWSWIRE) -- RESPILEAN In a world where we measure [...]

Global Healing’s Oxy-Powder® Demonstrates Powerful Gut Health Benefits in Citruslabs Study

02/04/2025 - 02:21

Global Healing's Oxy-Powder® demonstrated significant digestive health benefits in a recent Citruslabs study, with 95% of participants reporting constipation relief. The ozonated magnesium formula addresses root causes [...]

Portsmouth Square Completes Strategic Refinancing of Hilton San Francisco Financial District Hotel

02/04/2025 - 01:55

SAN FRANCISCO, CA, April 01, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. (OTC: PRSI) ("Portsmouth Square" or "the Company") today announced the successful refinancing of its flagship asset, the Hilton San Francisco [...]

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

02/04/2025 - 01:25

TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“ COSCIENS ” or the “ Company ”), a life science company which develops and commercializes a diversified portfolio [...]

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/04/2025 - 23:30

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for [...]

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

01/04/2025 - 23:00

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be [...]

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

01/04/2025 - 23:00

Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils [...]

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

01/04/2025 - 22:56

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ®  platform to develop drug-Fc conjugate (DFC) immunotherapies, today [...]

Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

01/04/2025 - 22:53

EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the [...]

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

01/04/2025 - 22:49

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived [...]

Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction

01/04/2025 - 22:45

Continued improvement of the Company’s financial position through additional reduction of outstanding debt by Madryn Asset Management TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or [...]

HCW Biologics Announces 1-for-40 Reverse Stock Split

01/04/2025 - 22:35

MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]

Respilean Review (BREAKING NEWS): Why Thousands Are Calling It the Natural Lung Breakthrough of 2025

01/04/2025 - 22:30

DENVER, April 01, 2025 (GLOBE NEWSWIRE) -- In a world where we measure everything—from step counts to calories—there’s one thing we rarely track until it’s already compromised: our lung health . With pollution rising, [...]

Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma

01/04/2025 - 22:30

Two posters will share data on the significant risk stratification provided by DecisionDx-Melanoma in a real-world cohort of patients with stage IIB-IIC cutaneous melanoma (CM) to help guide adjuvant therapy, and the [...]

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

01/04/2025 - 22:26

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi [...]

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/04/2025 - 22:15

FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) [...]

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

01/04/2025 - 22:09

RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously [...]

Stryker completes sale of U.S. spinal implants business

01/04/2025 - 22:05

Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi [...]